GC (GC Holdings) said on the 8th that it officially opened the GC&PHENIKAA Healthcare Center in Hanoi, Vietnam, on the 5th. The center was established as a joint venture between the GC group and the Phenikaa group in Vietnam.
According to the group, the GC&PHENIKAA Healthcare Center is equipped with a screening model that can analyze 14 major cancers and more than 30 diseases in about two hours. Based on a medical information system (HIS·LIS·PACS·EMR) developed by GC, it digitized the entire process from registration to testing, image reading, and results delivery. It also introduced a Non-chart System using an RF identification wristband, allowing visitors to undergo examinations without paperwork.
It also introduced an artificial intelligence (AI) diagnostic solution. It precisely analyzes imaging and test data to automatically detect early abnormal signs. This supports specialist reading and can improve diagnostic accuracy and efficiency.
GC emphasized that the opening of this screening center is meaningful as a platform for transfer and capacity building that passes on Korea's medical experience and technology to Vietnamese medical staff. The group plans to strengthen cooperation with local medical staff and share know-how in operating screening systems, supporting Vietnamese people to access medical services that meet international standards at an appropriate expense.
Heo Yong-jun, CEO of GC (GC Holdings), said, "Through this center, we will spread a prevention-centered health management culture and make a practical contribution to Vietnamese society."
Phenikaa-X, an affiliate of the Phenikaa group, and GC are jointly promoting the localization development of the medical information system (HIS). Using this center as a starting point, GC plans to expand its screening network to major cities in Vietnam and strengthen its Digital Healthcare business, including personalized healthcare and disease prediction services, based on the data it accumulates.